193 related articles for article (PubMed ID: 16083831)
1. Pathology and genetics of primary central nervous system and intraocular lymphoma.
Rubenstein JL; Treseler P; O'Brien JM
Hematol Oncol Clin North Am; 2005 Aug; 19(4):705-17, vii. PubMed ID: 16083831
[TBL] [Abstract][Full Text] [Related]
2. Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development.
Tateishi K; Miyake Y; Nakamura T; Yamamoto T
Brain Tumor Pathol; 2021 Jul; 38(3):173-182. PubMed ID: 34255226
[TBL] [Abstract][Full Text] [Related]
3. Primary intraocular lymphoma: A review.
Choi JY; Kafkala C; Foster CS
Semin Ophthalmol; 2006; 21(3):125-33. PubMed ID: 16912010
[TBL] [Abstract][Full Text] [Related]
4. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
Siepmann K; Rohrbach JM; Duncker G; Zierhut M
Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
[TBL] [Abstract][Full Text] [Related]
5. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas.
Malumbres R; Davis J; Ruiz P; Lossos IS
Br J Haematol; 2007 Sep; 138(6):749-55. PubMed ID: 17760806
[TBL] [Abstract][Full Text] [Related]
6. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.
D'Haene N; Catteau X; Maris C; Martin B; Salmon I; Decaestecker C
Br J Haematol; 2008 Feb; 140(4):402-10. PubMed ID: 18081894
[TBL] [Abstract][Full Text] [Related]
7. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis.
Capello D; Martini M; Gloghini A; Cerri M; Rasi S; Deambrogi C; Rossi D; Spina M; Tirelli U; Larocca LM; Carbone A; Gaidano G
Haematologica; 2008 Aug; 93(8):1178-85. PubMed ID: 18556404
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis, vascularity, and proliferation in primary central nervous system lymphomas (PCNSL): a histopathological study.
Roser F; Saini M; Meliss R; Ostertag H; Samii M; Bellinzona M
Surg Neurol; 2004 Nov; 62(5):393-9; discussion 399. PubMed ID: 15518841
[TBL] [Abstract][Full Text] [Related]
10. Classification, pathogenesis and molecular pathology of primary CNS lymphomas.
Paulus W
J Neurooncol; 1999 Jul; 43(3):203-8. PubMed ID: 10563424
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
Braggio E; Van Wier S; Ojha J; McPhail E; Asmann YW; Egan J; da Silva JA; Schiff D; Lopes MB; Decker PA; Valdez R; Tibes R; Eckloff B; Witzig TE; Stewart AK; Fonseca R; O'Neill BP
Clin Cancer Res; 2015 Sep; 21(17):3986-94. PubMed ID: 25991819
[TBL] [Abstract][Full Text] [Related]
12. Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging?
Küker W; Herrlinger U; Grönewäller E; Rohrbach JM; Weller M
J Neurol; 2002 Dec; 249(12):1713-6. PubMed ID: 12529795
[TBL] [Abstract][Full Text] [Related]
13. Unusual variants of primary central nervous system lymphoma.
Shenkier TN
Hematol Oncol Clin North Am; 2005 Aug; 19(4):651-64, vi. PubMed ID: 16083828
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system lymphoma newly developed 12 years after remission of an ocular adnexal lymphoma.
Morikawa K; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Ohshima K; Tsuda H
Acta Haematol; 2013; 130(4):247-50. PubMed ID: 23860499
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphoma.
Ferreri AJ; Reni M
Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
[TBL] [Abstract][Full Text] [Related]
16. Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
Courts C; Montesinos-Rongen M; Brunn A; Bug S; Siemer D; Hans V; Blümcke I; Klapper W; Schaller C; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2008 Jul; 67(7):720-7. PubMed ID: 18596541
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of p27 expression in primary central nervous system lymphoma.
Kunishio K; Nagao S
Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in primary central nervous system lymphomas.
Ferreri AJ; Reni M
Hematol Oncol Clin North Am; 2005 Aug; 19(4):629-49, vi. PubMed ID: 16083827
[TBL] [Abstract][Full Text] [Related]
19. Primary CNS lymphoma.
Hochberg FH; Baehring JM; Hochberg EP
Nat Clin Pract Neurol; 2007 Jan; 3(1):24-35. PubMed ID: 17205072
[TBL] [Abstract][Full Text] [Related]
20. Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas.
Nakamura M; Shimada K; Ishida E; Konishi N
Histol Histopathol; 2004 Jan; 19(1):211-9. PubMed ID: 14702189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
